A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics,...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
In the second post of the "Meet the Chairs" series, Mark Stewart, PhD, chair of the AACR's Associate Member...
March is Colorectal Cancer Awareness Month. About 134,490 people are estimated to be diagnosed with and about 49,190 are...
In the first post of the "Meet the Chairs" series, Scott Armstrong, MD, PhD, program chair of the 2016...
While the incidence of many cancer types is decreasing, endometrial cancer—a type of cancer that begins in the uterus...
Guest Post by Lee Gibbs Associate member of the American Association for Cancer Research (AACR) and doctoral candidate at the...
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved the immunotherapeutic obinutuzumab (Gazyva) for...
Josette Northcott, PhD, is exploring the role that blood vessels play in the growth of tumors and the delivery...
With the theme of “Shaping the Future of Cancer Prevention: A Roadmap for Integrative Cancer Science and Public Health,”...